Citizens Business Bank’s Gilead Sciences GILD Stock Holding History

Citizens Business Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06M	Sell	7,623 -18	-0.2%	-$2.52K	0.17%	75
2025 Q4	$938K	Sell	7,641 -46	-0.6%	-$5.59K	0.15%	73
2025 Q3	$853K	Buy	7,687 +1,099	+17%	+$125K	0.14%	75
2025 Q2	$730K	Sell	6,588 -103	-2%	-$11K	0.14%	75
2025 Q1	$750K	Buy	6,691 +4,321	+182%	+$446K	0.16%	74
2024 Q4	$612K	Sell	2,370 -4,277	-64%	-$385K	0.11%	80
2024 Q3	$557K	Sell	6,647 -206	-3%	-$15.7K	0.11%	89
2024 Q2	$470K	Buy	6,853 +1,586	+30%	+$106K	0.1%	93
2024 Q1	$386K	Buy	5,267 +45	+0.9%	+$3.46K	0.08%	96
2023 Q4	$423K	Buy	5,222 +301	+6%	+$23.4K	0.09%	86
2023 Q3	$369K	Sell	4,921 -257	-5%	-$19.8K	0.09%	88
2023 Q2	$399K	Buy	+5,178	New	+$413K	0.09%	86
2022 Q3	–	Sell	-24,905	Closed	-$1.54M	–	170
2022 Q2	$1.54M	Sell	24,905 -6	-0%	-$371	0.22%	108
2022 Q1	$1.48M	Buy	24,911 +12,337	+98%	+$789K	0.18%	128
2021 Q4	$913K	Sell	12,574 -112	-0.9%	-$7.71K	0.11%	173
2021 Q3	$886K	Buy	12,686 +3,210	+34%	+$226K	0.12%	169
2021 Q2	$653K	Buy	9,476 +2,576	+37%	+$172K	0.09%	189
2021 Q1	$446K	Hold	6,900	–	–	0.06%	196
2020 Q4	$402K	Hold	6,900	–	–	0.06%	200
2020 Q3	$436K	Hold	6,900	–	–	0.07%	180
2020 Q2	$531K	Hold	6,900	–	–	0.09%	173
2020 Q1	$516K	Hold	6,900	–	–	0.11%	169
2019 Q4	$448K	Sell	6,900 -11,800	-63%	-$768K	0.07%	194
2019 Q3	$1.19M	Hold	18,700	–	–	0.2%	133
2019 Q2	$1.26M	Hold	18,700	–	–	0.21%	131
2019 Q1	$1.22M	Sell	18,700 -500	-3%	-$33.2K	0.21%	134
2018 Q4	$1.2M	Sell	19,200 -20,700	-52%	-$1.45M	0.23%	120
2018 Q3	$3.08M	Sell	39,900 -5,400	-12%	-$408K	0.52%	45
2018 Q2	$3.21M	Buy	45,300 +6,100	+16%	+$431K	0.56%	40
2018 Q1	$2.96M	Sell	39,200 -2,750	-7%	-$219K	0.52%	49
2017 Q4	$3M	Buy	41,950 +5,928	+16%	+$450K	0.49%	57
2017 Q3	$2.92M	Buy	36,022 +5,655	+19%	+$432K	0.49%	54
2017 Q2	$2.15M	Sell	30,367 -8,406	-22%	-$559K	0.36%	74
2017 Q1	$2.63M	Buy	38,773 +13,358	+53%	+$939K	0.44%	61
2016 Q4	$1.82M	Sell	25,415 -1,675	-6%	-$125K	0.32%	78
2016 Q3	$2.14M	Sell	27,090 -1,780	-6%	-$145K	0.4%	69
2016 Q2	$2.41M	Sell	28,870 -781	-3%	-$69.3K	0.45%	60
2016 Q1	$2.72M	Sell	29,651 -2,131	-7%	-$192K	0.51%	57
2015 Q4	$3.22M	Sell	31,782 -2,503	-7%	-$260K	0.62%	48
2015 Q3	$3.37M	Sell	34,285 -1,175	-3%	-$130K	0.63%	42
2015 Q2	$4.15M	Sell	35,460 -1,474	-4%	-$161K	0.72%	35
2015 Q1	$3.63M	Buy	36,934 +1,113	+3%	+$113K	0.64%	51
2014 Q4	$3.38M	Sell	35,821 -8,915	-20%	-$922K	0.61%	57
2014 Q3	$4.76M	Buy	44,736 +630	+1%	+$61.7K	0.92%	18
2014 Q2	$3.66M	Sell	44,106 -659	-1%	-$51.3K	0.7%	38
2014 Q1	$3.17M	Buy	44,765 +26,623	+147%	+$2.09M	0.61%	49
2013 Q4	$1.36M	Buy	18,142 +5,123	+39%	+$357K	0.27%	108
2013 Q3	$819K	Buy	13,019 +7,781	+149%	+$465K	0.18%	148
2013 Q2	$269K	Buy	+5,238	New	+$273K	0.06%	232

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Citizens Business Bank's GILD Position: Q1 2026 in Review

Citizens Business Bank reduced its Gilead Sciences (GILD) stake by 0.24% in Q1 2026, selling an estimated $2.52K and leaving 7,623 shares worth $1.06M. The position accounts for 0.17% of the portfolio, ranked #75.

Citizens Business Bank first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. The position peaked at $4.76M in Q3 2014. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Citizens Business Bank held 7,623 shares of Gilead Sciences worth $1.06M as of Q1 2026.
Citizens Business Bank sold 18 Gilead Sciences shares in Q1 2026, an estimated $2.52K.
Gilead Sciences made up 0.17% of Citizens Business Bank's portfolio in Q1 2026, its #75 holding.
Citizens Business Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
Citizens Business Bank's Gilead Sciences position peaked at $4.76M in Q3 2014.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Citizens Business Bank's 13F filing for Q1 2026, filed 1 May 2026.